PE
RXST icon

PCM Encore’s RxSight RXST Stock Holding History

PCM Encore’s Portfolio RXST Stock Details RXST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-20,278
Closed -$125K – 485
2026
Q1 		$125K Sell
20,278
-121
-0.6% -$1K 0.03% 430
2025
Q4 		$213K Buy
+20,399
New +$205K 0.05% 394

Other funds holding RXST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
NSGL
No Street GP LP San Francisco, California $1.66B AUM 39.91% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

PCM Encore's RXST Position: Q2 2026 in Review

PCM Encore sold out of RxSight (RXST) in Q2 2026, closing a stake of 20,278 shares — an estimated $125K sold.

PCM Encore first reported a position in RXST in Q4 2025 and held it in 2 quarters. The position peaked at $213K in Q4 2025. 151 funds tracked by Wall St. Rank hold RXST as of Q2 2026.

  • PCM Encore reported no remaining RxSight position as of Q2 2026 after selling out during the quarter.
  • PCM Encore sold 20,278 RxSight shares in Q2 2026, an estimated $125K.
  • PCM Encore first reported a position in RxSight in Q4 2025 and held it in 2 quarters.
  • PCM Encore's RxSight position peaked at $213K in Q4 2025.
  • 151 funds tracked by Wall St. Rank held RxSight as of Q2 2026.

Based on PCM Encore's 13F filing for Q2 2026, filed 11 Aug 2026.